0001179110-18-005443.txt : 20180404 0001179110-18-005443.hdr.sgml : 20180404 20180404201456 ACCESSION NUMBER: 0001179110-18-005443 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180402 FILED AS OF DATE: 20180404 DATE AS OF CHANGE: 20180404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bukofzer Stan CENTRAL INDEX KEY: 0001663041 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 18738769 MAIL ADDRESS: STREET 1: C/O OCERA THERAPEUTICS STREET 2: 525 UNIVERSITY AVENUE, SUITE 610 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-744-8000 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD. STREET 2: SUITE 300 CITY: NEWARK STATE: CA ZIP: 94560 4 1 edgar.xml FORM 4 - X0306 4 2018-04-02 0 0001005201 DEPOMED INC DEPO 0001663041 Bukofzer Stan C/O DEPOMED, INC 7999 GATEWAY BLVD SUITE 300 NEWARK CA 94560 0 1 0 0 Chief Medical Officer & SVP*** Restricted Stock Units 2018-04-02 4 A 0 91324 0 A Common Stock 91324 91324 D Each Restricted Stock Unit represents the contingent right to receive one share of common stock upon vesting of the unit. These Restricted Stock Units are scheduled to vest 27.78% on April 2, 2019, 27.78% on April 2, 2020 and 44.44% on April 2021 assuming continued employment through the applicable vesting date. *** Stanley's title is Chief Medical and Scientific Officer, Senior Vice President. Stanley Bukofzer 2018-04-04